These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9432468)

  • 21. Positron-emitting radiopharmaceuticals: how safe are they?
    Silberstein EB
    Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793
    [No Abstract]   [Full Text] [Related]  

  • 22. Positron emission tomography scanning: a primer.
    Walker RC; Weiss DW; Purnell GL; Forte KF
    J Ark Med Soc; 2002 Oct; 99(4):119-21. PubMed ID: 12362654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isotopic labeling with short-lived radionuclides represents the future for clinical PET imaging. For the proposition.
    Harkness B
    Med Phys; 2002 Dec; 29(12):2897-8. PubMed ID: 12512725
    [No Abstract]   [Full Text] [Related]  

  • 24. A brief history of positron emission tomography (PET).
    Wagner HN
    Semin Nucl Med; 1998 Jul; 28(3):213-20. PubMed ID: 9704363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Netherlands' experience in positron emission tomography in thoracic oncology].
    Hoekstra O
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S25-7. PubMed ID: 12538930
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebral fluorine-18 fluorodeoxyglucose positron emission tomographic findings in x-linked adrenoleukodystrophy.
    Bakheet S; Al-Essa M; Patay Z; Al-Watban J; Dhaunsi G; Powe J; Ozand PT
    Clin Nucl Med; 1999 May; 24(5):364-5. PubMed ID: 10232485
    [No Abstract]   [Full Text] [Related]  

  • 27. Nuclear oncology and the Imagene concept.
    Urbain JL; Vekemans MC; Lemieux SK; Cosenza SC; Senadhi VK; Milestone BN; Reddy EP
    Acta Radiol Suppl; 1997; 412():21-8. PubMed ID: 9240077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonisotopic substitution: is fluorine a replacement for hydrogen?
    Duatti A
    Nucl Med Biol; 2013 Oct; 40(7):871-2. PubMed ID: 23886848
    [No Abstract]   [Full Text] [Related]  

  • 29. Conference at the French Senate. Regulation and quality of nuclear medicine: a case study in the health field. 2 October 1998, Palais du Luxembourg, Paris, France.
    Ell PJ
    Eur J Nucl Med; 1999 Feb; 26(2):186-8. PubMed ID: 10223841
    [No Abstract]   [Full Text] [Related]  

  • 30. 1999: main diagnostic applications of nuclear medicine in oncology. Task Group of Oncology, World Federation of Nuclear Medicine and Biology.
    Eur J Nucl Med; 1999 May; 26(5):BP21-7. PubMed ID: 10382102
    [No Abstract]   [Full Text] [Related]  

  • 31. [Basic research and clinical application (author's transl)].
    Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):692-6. PubMed ID: 693910
    [No Abstract]   [Full Text] [Related]  

  • 32. PET scanning in clinical oncology.
    Timothy AR; Cook GJ
    Ann Oncol; 1998 Apr; 9(4):353-5. PubMed ID: 9636824
    [No Abstract]   [Full Text] [Related]  

  • 33. Lesion detectability and quantitative recovery with FDG-PET.
    Links JM
    Eur J Nucl Med; 1999 Jun; 26(6):681-2. PubMed ID: 10428608
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recommendations for the use of PET-CT with 18F-FDG in radiotherapy planning].
    García Vicente AM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):364. PubMed ID: 23063325
    [No Abstract]   [Full Text] [Related]  

  • 35. The future of positron emission tomography in oncology depends on interactive basic, nuclear and clinical research.
    Buell U; Cremerius U; Zimny M
    Eur J Nucl Med; 1997 Oct; 24(10):1330. PubMed ID: 9432468
    [No Abstract]   [Full Text] [Related]  

  • 36. [Whole body positron emission tomography (PET) with (18F)-fluorodeoxyglucose].
    Grupo PET de la SEMN
    Rev Esp Med Nucl; 2002 Apr; 21(2):128-30. PubMed ID: 11879625
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical PET: are we ready?
    Coleman RE; Tesar RD
    J Nucl Med; 1997 Dec; 38(12):16N, 24N. PubMed ID: 9430451
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.